Keyphrases
Tumor Size
100%
Long-term Prognosis
100%
Patients with Breast Cancer
100%
Nuclear Size
100%
Fraction Size
100%
Estrogen Receptor
83%
Progesterone Receptor
66%
Multivariate Analysis
33%
Axillary Lymph Node
33%
Relapse-free Survival
33%
Labeling Index
33%
Lymph Node Status
33%
Lymph Node Tumour
33%
DNA Labeling
33%
Disease Classification
16%
Long-term Survival
16%
Histopathological Features
16%
Unanswered Questions
16%
Flow Cytometry
16%
Survival Plots
16%
Kaplan-Meier
16%
Plot Analysis
16%
Disease-specific
16%
Strong Predictor
16%
Prognosis Prediction
16%
Breast Cancer Survival
16%
Paraffin-embedded Tissue
16%
Tritiated Thymidine
16%
Axillary Lymph Node Dissection
16%
Long-run Risk
16%
Axillary Lymph Node Metastasis
16%
Relative Efficacy
16%
Metastasis Risk
16%
DNA Ploidy
16%
Axillary Lymph Node Status
16%
DNA Flow Cytometry
16%
Optical Grid
16%
Lymph Nodal Status
16%
Medicine and Dentistry
Neoplasm
100%
Estrogen Receptor
100%
Breast Cancer
100%
Progesterone Receptor
80%
Axillary Lymph Node
80%
Metastatic Carcinoma
40%
Lymph Node
40%
Flow Cytometry
40%
Multivariate Analysis
40%
Recurrence Free Survival
40%
In Vitro
20%
Thymidine
20%
Long Term Survival
20%
Lymphoma
20%
Nosology
20%
Cytosol
20%
Retroperitoneal Lymph Node Dissection
20%
Cancer Specific Survival
20%
Ploidy
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Breast Cancer
100%
Estrogen Receptor
100%
Progesterone Receptor
80%
Flow Cytometry
40%
Recurrence Free Survival
40%
Lymphoma
20%
Long Term Survival
20%
Thymidine
20%
Cancer Specific Survival
20%
Disease Classification
20%
Diseases
20%
Immunology and Microbiology
Tumor Volume
100%
Nuclear Size
100%
Axillary Lymph Node
66%
Lymph Node
33%
Recurrence Free Survival
33%
Cytosol
16%
Long Term Survival
16%
Ploidy
16%
Disease Classification
16%
Cancer Specific Survival
16%
Optics
16%